Bacteroides fragilis is an important opportunistic pathogen of humans and is resistant to many drugs commonly used to treat anaerobic infections, including P-lactams. A strain set comprised of B. fragilis isolates producing either low or high levels of the endogenous cephalosporinase activity, CepA, has been described previously (M. B. Rogers, A. C. Parker, and C. J. Smith, Antimicrob. Agents Chemother. 37:2391-2400.Clones containing cepA genes from each of seven representative strains were isolated, and the DNA sequences were determined. Nucleotide sequence comparisons revealed that there were few differences between the cepA coding sequences of the low-and high-activity strains. The cepA coding sequences were cloned into an expression vector, pFD340, and analyzed in a B.fragilis 638 cepA mutant. The results of j-lactamase assays and ampicillin MICs showed that there was no significant difference in the enzymatic activity of structural genes from the high-or low-activity strains. Comparison of sequences upstream of the cepA coding region revealed that 50 bp prior to the translation start codon, the sequence for high-activity strains change dramatically. This region of the high-activity strains shared extensive homology with IS21, suggesting that an insertion was responsible for the increased expression of cepA in these isolates. Northern (RNA) blot analysis of total RNA by using cepA-specific DNA probes supported the idea that differential cepA expression in low-and high-activity strains was controlled at the level of transcription. However, the insertion did not alter the cepA transcription start site, which occurred 27 bp upstream of the ATG translation start codon in both expression classes. Possible mechanisms of cepA activation are discussed.The anaerobe Bacteroides fragilis contains an endogenous, chromosomally encoded P-lactamase which preferentially hydrolyzes cephalosporins and is responsible for the intrinsic resistance to most penicillins and cephalosporins (6, 15). These organisms are generally susceptible to some of the newer ,B-lactams such as cephamycins (cefoxitin) and carbapenems (imipenem), although newly acquired 3-lactamases capable of degrading these antibiotics have been described (18,21,38).The indigenous 3-lactamase is present in between 90 and 99% of B. fragilis strains and at the biochemical level, this P-lactamase has been shown to be species specific (8,16). Recently, the gene for this enzyme, cepA, was cloned and the nucleotide sequence was determined (27). Southern hybridization analyses with a cepA probe showed that there was homology only with other B. fragilis strains, and construction of a cepA mutant provided evidence that this gene did in fact encode for the endogenous ,-lactamase. Comparison of the predicted CepA amino acid sequence with other 3-lactamase sequences indicated that it was not in the Ambler molecular class C like the chromosomal ,-lactamases of most other gram-negative bacteria, but rather CepA belonged to the class A 3-lactamases. The CepA enzyme together with...